Justin Hanes

Justin Hanes received a B.S. in Chemical Engineering from UCLA in 1991 and Ph.D. in Chemical Engineering from MIT in 1996. He did postdoctoral training in Oncology and Neurosurgery at the Johns Hopkins University School of Medicine in 1996-1998. He is a full Professor at Johns Hopkins University, with appointments in the Departments of Ophthalmology, Biomedical Engineering, Chemical & Biomolecular Engineering, Environmental Health Sciences, Neurosurgery and Oncology.

He is the Director of the Center for Nanomedicine at the Johns Hopkins University School of Medicine, where he leads a laboratory of more than 40 scientists and engineers. He also serves on the Executive Committee and as Director of Therapeutics for the Institute for NanoBioTechnology at Johns Hopkins.

He has published widely and is an inventor on more than 15 patent families, many of which have been licensed to industry. He has given more than 100 invited lectures and has received numerous honors and awards , including being named among the World's Top 100 Young Innovators and Leaders in Technology and Business, by the MIT Technology Review in 2003.

He was also named a Global Young Leader by the U.S. National Academy of Sciences, and selected as a representative of the U.S. to attend the Meeting of the New Champions at the World Economic Forum in Tianjin, China in 2008.

He currently serves on the scientific advisory board for Genentech, Inc.'s Drug Delivery Division and is a founder and director of Kala Pharmaceuticals, where he also serves as the Chair of the Scientific Advisory Board.

Justin Hanes is the Founder, Director & Former CEO at GrayBug, based in United States, North America. With a background in Biotechnology, Justin Hanes has a rich history of leadership and innovation.Justin Hanes studied Ph.D. Chemical Engineering at Massachusetts Institute of Technology. Explore their detailed professional journey, key connections, and contributions to the industry on our platform.